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ABSTRACT
Aflatoxin B1 (AFB1), a class 1 carcinogen and prominent food contaminant, 
is highly linked to the development of hepatocellular carcinoma (HCC) and plays a 
causative role in a large portion of global HCC cases. We have demonstrated that a 
mixture of common organic acids (citric and phosphoric acid) along with arginine can 
eliminate >99% of AFB1 in solution as well as on corn kernels and convert it to the 
AFB2a-Arg adduct, acting as a potential detoxification process for contaminated foods. 
Evaluation of toxicokinetic changes after AFB2a-Arg formation show that the product 
is highly stable in biological fluids, is not metabolized by P450 enzymes, is highly 
plasma protein bound, has low lipid solubility, and has poor intestinal permeability/
high intestinal efflux compared to AFB1. Ames’ test results show that at mutagenic 
concentrations of AFB1, AFB2a-Arg does not have any measurable mutagenic effect 
which was confirmed by DNA adduct identification by liquid chromatography-mass 
spectrometry. Evaluation in HepG2 and HepaRG cells showed that AFB2a-Arg did 
not cause any significant decreases in cell viability nor did it increase micronuclei 
formation when administered at toxic concentrations of AFB1. These results show 
that conversion of AFB1 to AFB2a-Arg is a potential strategy to detoxify contaminated 
foods.
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INTRODUCTION
Aflatoxins are a group of mycotoxins produced by 
the fungi Aspergillus flavus and Aspergillus parasictus 
which frequently contaminate many varieties of the 
world’s crops, particularly maize, groundnuts, and wheats 
[1–5]. Out of the compounds belonging to this class, 
aflatoxin B1 (AFB1) is the most toxic of the aflatoxins. As 
a class 1 carcinogen, chronic dietary exposure to AFB1 has 
been identified as a major risk factor for the development 
of hepatocellular carcinoma (HCC) particularly when an 
individual is also infected with hepatitis B virus [6–10]. 
AFB1 initiates the development of HCC through 
mutagenesis which occurs after it is metabolized in 
the liver to aflatoxin-8,9-epoixde (AFBO), a bioactive 
metabolite which spontaneously binds irreversibly to 
guanine residues forming AFB1-N7-Guanine adducts 
which lead to the development of point mutations [11, 12]. 
In addition to HCC, links between AFB1 exposure and 
growth suppression as well as immune system modulation 
have been shown, amplifying its status as a public health 
concern [13–15]. Sub-Saharan Africa and Southeast 
Asia are the regions which possess the highest risk of 
exposure to aflatoxins and have experienced aflatoxin 
outbreaks severe enough to cause hundreds of deaths due 
to acute toxicities [16–18]. While these areas experience 
the greatest burden of aflatoxins, it is predicted that as 
the average global temperature increases due to climate 
change, many countries may experience greater risks of 
aflatoxin exposure in the future [19].
Many strategies to manage aflatoxin contamination 
in crops have been studied to alleviate global exposure 
rates. Because contamination can occur at both the pre- and 
post-harvest stage, these approaches have included various 
agricultural practices (i.e. irrigation/pesticide practices, use 
of genetically modified seeds which are mold-resistant), 
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drying and storage techniques, as well as various food 
processing strategies [20]. Due to the unpredictable timing 
of contamination, food processing techniques have gained 
popularity due to the ability to reduce exposure just prior 
to ingestion. These often incorporate chemoprotection, 
enterosorption, acidification/alkalization, or other methods 
of chemical treatment to inactivate, modify, or remove 
AFB1 [21, 22]. Many of these methods have limited 
efficacy or other logistical limitations that have prevented 
their use by various populations (i.e. necessitates high cost 
equipment, requires chronic dosing of individuals with 
medications/supplements). Additionally, transformation 
products that may arise from these detoxification methods 
may still retain genotoxic activity or even be reversible 
back to AFB1 [23, 24], demonstrating that transformation 
products must be fully evaluated to ensure detoxification. 
As a result, there is a large need for a decontamination 
method that is effective, forms inert products, and is 
relatively easy to implement into societies of varying 
economic status.
Recently, our lab has investigated the efficacy 
of common organic acids or acidic environmental 
conditions to transform AFB1 into aflatoxin B2a 
(AFB2a) - an AFB1 metabolite which has shown to have 
reduced mutagenicity due to hydration of the 8,9-double 
bond [25–27]. Although in vivo data is limited, AFB2a 
has still been shown to have some hepatotoxic effects 
at high doses and there is a concern for its ability to 
spontaneously dehydrate back to AFB1, so its role as a 
detoxification end-product is unclear [28]. One property 
of AFB2a that likely contributes to its hepatotoxic effects 
is protein binding which, in a second study, we have 
shown that this adduct forms through the creation of a 
pyrrole ring [29]. Formerly thought to be formed through 
Schiff bases, this AFB2a-amine adduct is more stable 
than previously suggested and can be formed under 
mild acidic conditions. In this study, we hypothesized 
that AFB1 could be transformed into AFB2a and then 
subsequently adducted to an amino acid in a single 
acidification step. We also hypothesized that this reaction 
product would not be genotoxic due to the irreversible 
removal of the 8,9-double bond and/or by changing 
various toxicokinetic parameters to prevent the product 
from reaching the liver. Based on our previous work, 
arginine was chosen as the amino acid for adduction 
based on its high polarity previously determined by 
HPLC and the high pKa of its retained side chain which 
would remain charged at physiological pHs (Figure 1). 
These properties were expected to decrease the adduct’s 
affinity for nonpolar environments, decreasing its lipid 
solubility and membrane permeability thereby increasing 
its effectiveness as a detoxification product.
RESULTS
Development of a treatment method to detoxify 
AFB1
Because AFB1 can be transformed into AFB2a 
which can then adduct to amines under acidic conditions, 
we investigated the transformation of AFB1 into AFB2a-
Arg in a single treatment step across multiple acidic pH 
values. In previous work, we found that by adding various 
concentrations of citric acid into simulated gastric fluid, 
the transformation of AFB1 into AFB2a was greatly 
enhanced even though the pH remained unchanged [25]. 
Therefore, we also tested the effect of having either citric 
acid, phosphoric acid, or both present in the solution 
at each pH level. Using HPLC-MS, we were able to 
develop a method to detect the presence of AFB1 as 
well as AFB2a-Arg as the detoxification product after 
boiling each treatment solution for 20 min (Figure 2A 
and 2B). In general, as pH decreased, the amount of AFB1 
remaining in solution decreased. The presence of citric and 
phosphoric acid, particularly in combination, enhanced 
AFB1 degradation even though the pH of the solution was 
the same as the H2O controls (Figure 2C). In accordance 
with AFB1 degradation, AFB2a-Arg production was 
Figure 1: Chemical conversion of AFB1 to AFB2a-Arg is carried out by the AFB2a intermediate. Formed by hydration 
of AFB1 under acidic conditions, AFB2a spontaneously converts to a dialdehyde which is favored under alkaline conditions. This AFB2a 
dialdehyde is then able to react with the primary amine group of arginine through the formation of a pyrrole ring.
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greatest in solutions at lower pH values and with those that 
contained the organic acids, especially in combination. 
The most effective treatment solution, which degraded the 
most AFB1 and formed the most AFB2a-Arg, was one that 
contained both acids and was adjusted to a pH value of 3 
(Figure 2D).
Because this composition was most effective 
on AFB1 standards, it was also tested for its ability to 
detoxify AFB1-spiked corn kernels. After treatment was 
applied to the contaminated corn, no detectable AFB1 
was found on the corn surface or in the treatment solution 
itself. Some removal of AFB1 from the food surface could 
be attributable to water solubility of AFB1 as shown by 
the water washed group. However, this only removed 
approximately 40% of AFB1 which was found in the water 
solution itself untransformed (Figure 2E). When analyzing 
the treated corn, the detoxification product AFB2a-Arg 
was only found in the treatment solution and none was 
detected on the food substrate (Figure 2F). This shows that 
the treatment solution was not only able to remove AFB1 
from the contaminated food, but it was also able to fully 
transform it into the arginine adduct. 
Toxicokinetic differences between AFB1 and 
AFB2a-Arg
A series of in vitro ADME tests were applied 
to AFB1 and AFB2a-Arg to determine any favorable 
toxicokinetic changes that may result from the 
transformation process. When incubated in simulated 
gastric fluid, simulated intestinal fluid, or pooled 
human plasma, AFB2a-Arg remained approximately 
94%, 99%, and 102% stable in all compartments. 
Furthermore, AFB2a-Arg was significantly more 
stable than AFB1 in simulated gastric fluid which was 
hydrated into AFB2a under the low pH conditions 
(Figure 3A). These data indicate that AFB2a-Arg is 
stable in all three biological compartments, evading 
breakdown by hydrolysis or hydration. AFB2a-Arg 
was not significantly degraded by hepatic microsomal 
enzymes in contrast to AFB1 which was degraded 
by approximately 75% (Figure 3B). This lack of 
microsomal degradation shows that AFB2a-Arg is not 
a substrate for phase I metabolism, preventing hepatic 
oxidation into epoxides or other reactive metabolites. 
Figure 2: AFB1 can be converted to AFB2a-Arg in a single step using solutions containing organic acids and arginine. 
AFB2a-Arg standards were distinguished from AFB1 standards and quantified using extracted ion chromatograms (A) which were formed 
based on accurate mass spectra (B) (left – AFB1, right – AFB2a-Arg) to develop an HPLC-MS method. Standards of AFB1 were dissolved in 
arginine solutions containing various combinations of citric and/or phosphoric acid at various pH levels. After boiling for 20 min, disappearance 
of AFB1 (C) and formation of AFB2a-Arg (D) was observed. Taking the optimal conditions from this experiment, corn kernels spiked with 
AFB1 were treated and then analyzed for AFB1 (E) and AFB2a-Arg (F) that either remained on the corn or was dissolved in the treatment 
solution. All error bars are expressed as SEM. Asterisks denote statistical significance from the control (p < 0.05).
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Plasma protein binding measured by rapid 
equilibrium dialysis (RED) showed that AFB2a-Arg was 
99% protein bound as opposed to AFB1 which was only 
82% bound (Figure 3C). The highly polar, positively 
charged arginine side chain of AFB2a-Arg likely interacts 
very strongly with acidic residues of plasma proteins, 
increasing the strength of the interaction between the two. 
High affinity to plasma proteins decreases the portion of 
free AFB2a-Arg and could limit any biological effects 
it may have. However, the elimination rates may also 
be decreased due to this property, possibly increasing 
the biological half-life as compared to AFB1. When 
evaluating octanol-water partition coefficients, AFB2a-
Arg showed very little partitioning into the octanol fraction 
leading to a lower partition coefficient than AFB1 or 
AFB2a (Figure 3D). This lowered lipid solubility suggests 
that AFB2a-Arg would have a greater difficulty passing 
through membranes particularly through passive diffusion. 
In agreement with this, the intestinal permeability of 
AFB2a-Arg, determined by the Caco-2 permeability 
assay, was also shown to be significantly lower than AFB1 
(Figure 3E). Such poor intestinal permeability indicates 
that upon ingestion, AFB2a-Arg is much less likely to 
be absorbed into systemic circulation than AFB1. This 
is further highlighted by the observation that AFB2a-Arg 
demonstrated a significantly higher efflux ratio than AFB1 
in Caco-2 cells (Figure 3F) which indicates that if any 
AFB2a-Arg is absorbed, a large portion of it will likely 
be effluxed back out into the lumen or extracellular space.
Loss of mutagenicity after transformation of 
AFB1 into AFB2a-Arg
To compare the mutagenic potential of AFB1 and 
the newly formed AFB2a-Arg, both compounds were 
evaluated by an Ames’ test and by their ability to form 
adducts with DNA as determined by HPLC-MS. In 
agreement with previous studies [27], Ames’ test results 
showed that at concentrations of 30 and 50 ng/well, AFB1 
showed a significant increase in the number of revertant 
wells indicating a robust mutagenic response. In contrast, 
AFB2a-Arg did not show any significant differences 
from the vehicle at the same concentrations (Figure 4A). 
When incubated with DNA and liver microsomes, UV 
chromatograms showed the formation of a new peak that 
absorbed strongly at 365 nm (Figure 4B). Upon analyzing 
mass spectral data for this peak, the accurate mass of AFB1-
N7-Guanine (m/z 480.115) was discovered which gave a 
Figure 3: Conversion of AFB1 to AFB2a-Arg leads to changes in toxicokinetics. The stability of AFB1 and AFB2a-Arg 
in biological fluids (A) and with hepatic microsomes (B) showed that AFB2a-Arg was more stable in acidic environments and was not 
metabolized by P450 enzymes. RED experiments showed that AFB2a-Arg was more highly protein-bound (C) and logP measurements 
demonstrated much poorer lipid solubility than AFB1 (D). Lastly, Caco-2 permeability assays showed that AFB2a-Arg had significantly 
less intestinal permeability (E) and higher intestinal efflux capacity (F) than AFB1. All error bars are expressed as SEM. Asterisks denote 
statistical significance from the control (p < 0.05).
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strong peak in the extracted ion chromatogram indicating 
the presence of DNA adduction (Figure 4C). This m/z has 
also been previously used to identify AFB1-N7-Guanine 
and has been correlated to AFB1 exposure and toxicity [33, 
34]. When AFB2a-Arg was incubated with DNA and liver 
microsomes, no additional peaks were discovered in the UV 
chromatograms (Figure 4D) and mass spectral data showed 
no accurate masses that would correspond to any theoretical 
DNA adducts (data not shown). These data indicate that 
AFB2a-Arg does not show any mutagenic potential at 
concentrations that show clear, robust responses with AFB1.
Genotoxicity and cytotoxicity of AFB1 and 
AFB2a-Arg in human hepatocyte cell lines
To determine hepatotoxic effects of AFB2a-
Arg with AFB1, genotoxicity and cytotoxicity were 
measured after exposing HepG2 and HepaRG cells to 
both compounds. Results showed that by observing cell 
viability, AFB1 significantly reduced the percentage of 
viable cells at concentrations >7.5 µM and >3.75 µM 
for HepG2 and HepaRG cells respectively. In contrast, 
AFB2a-Arg showed no significant decreases in cell 
viability in all concentrations tested (Figure 5A and 5B). 
When analyzing concentrations that contained >25% cell 
viability for both AFB1 and AFB2a-Arg treated cells, AFB1 
treated cells showed a significant increase in the number 
of micronuclei in both HepG2 and HepaRG cell lines 
whereas AFB2a-Arg did not show this genotoxic marker 
(Figure 5C and 5D). Although micronuclei percentage 
at higher concentrations are not displayed due to high 
AFB1 induced cell death, AFB2a-Arg also did not increase 
micronuclei formation all the way up to the 60 µM used 
in this study. The effects of AFB1 at the dosages used in 
this study are comparable to genotoxic responses shown in 
previous studies using both HepG2 and HepaRG cell lines 
[35–37]. The higher metabolic activity of HepaRG cells 
likely contributes to the increased sensitivity and range 
of micronuclei that were observed as compared to HepG2 
cells. Taken together, these data show that AFB2a-Arg 
does not lead to genotoxicity in human liver cell lines. 
Additionally, the absence of cytotoxicity also supports a 
lack of overall hepatotoxicity of AFB2a-Arg. 
DISCUSSION
Various studies have shown that food supplies 
in many countries are contaminated with high levels of 
Figure 4: Conversion of AFB1 to AFB2a-Arg removes mutagenicity through eliminating DNA adduct formation. Ames’ 
test results showed that at equivalent concentrations, AFB2a-Arg did not cause mutations although AFB1 showed a robust response (A). 
Incubations of AFB1 with DNA and liver microsomes showed the formation of a unique peak (2.9 min) in the HPLC UV chromatogram 
(B) which corresponded to the extracted ion chromatogram of the accurate mass of AFB1-N7-Guanine (C) (accurate mass spectra of 
AFB1-N7-Guanine shown in insert). Incubation of AFB2a-Arg with DNA and liver microsomes showed no unique peaks in the HPLC UV 
chromatogram indicating no DNA adduct formation (D). All error bars are expressed as SEM. Asterisks denote statistical significance from 
the control (p < 0.05).
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AFB1. Ingestion of AFB1 through these contaminated 
foods has been strongly linked with carcinogenicity 
and it does so through damaging genetic material [38]. 
As a result, treatment of contaminated foods has been a 
widely studied area and many strategies involve methods 
that chemically modify AFB1. Some studies simply look 
at AFB1 disappearance, however this is not sufficient 
evidence of detoxification because some transformation 
products may still retain the original compound’s toxicity. 
Additionally, many of these transformation products 
are also not evaluated for kinetic properties such as 
metabolism or bioavailability. Also, the treatment methods 
themselves have various limitations such as insufficient 
efficacy or logistical issues regarding practical use [39]. 
As a result, there is still a great need to discover new 
methods to detoxify contaminated foods. 
In this study, we explored the possibility to 
transforming AFB1 into an amino acid adduct and the 
changes this transformation has on the toxicokinetic 
or toxicodynamic properties of the original AFB1. Our 
findings show that after treating contaminated foods 
with a mixture of organic acids and arginine at acidic pH 
values, a full conversion of AFB1 into AFB2a-Arg can be 
achieved in 20 minutes without the use of any specialized 
equipment. A panel of in vitro ADME tests were applied to 
both compounds and the data showed that AFB2a-Arg was 
highly stable, was not metabolized, had a reduced ability 
to be absorbed through the intestine, and had a lowered 
ability to distribute to target organs due to high plasma 
protein binding. Lastly, AFB2a-Arg showed no mutagenic, 
genotoxic, or cytotoxic potential in bacterial cells or in 
cultured human hepatocytes. Taken together, the data 
suggest that AFB2a-Arg can be easily formed from AFB1 
and the transformation is an effective method to reduce 
AFB1 toxicity (Figure 6).
AFB2a-Arg formation was enhanced in the presence 
of organic acids, at constant pH values, even though 
protonation is the rate limiting step in hydration reactions 
of alkenes. One would expect that the solution pH itself 
should be the determining factor in the conversion of 
AFB1 to AFB2a regardless of other dissolved species. 
However, the observation seen in this study is in 
agreement with our previous findings concerning AFB2a 
formation in gastric fluid containing citric acid [25]. It 
could be that the presence of the organic acids helps to 
buffer the treatment solution during boiling to keep the 
pH constant, or perhaps the conjugate bases of these acids 
stabilize the intermediate species to enhance the hydration. 
Exploring the use of other buffering species in this 
treatment process may be useful in further optimization 
of this detoxification. Additionally, longer boiling times 
may be used with lower acid concentrations to achieve the 
Figure 5: Cytotoxicity and genotoxicity measurements in cultured human hepatocyte cell lines. Cell viability was measured 
in HepG2 (A) and HepaRG (B) by flow cytometry after 24 hours of treatment with AFB1 or AFB2a-Arg followed by 72 hours of recovery. 
Using the same treatment paradigm, the percentage of cells containing micronuclei (MN) was also measured by flow cytometry  in HepG2 
(C) and HepaRG (D) cells as a measure of genotoxicity. Both endpoints showed that AFB2a-Arg, in contrast to AFB1, caused no hepatocyte 
cell death or micronuclei formation. All error bars are expressed as SEM. Asterisks denote statistical significance from the control (p < 0.05).
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same effect. These options may lead to even cheaper or 
convenient methods to treat contaminated foods.  
The approach for the current study used in vitro 
methods to assess our detoxification product, however 
in vivo methods may useful in confirming or expanding 
this evaluation. Such information would useful to further 
explore the bioavailability of AFB2a-Arg as well as its 
excretion. Additionally, AFB2a-Arg may be a substrate 
for other enzymes outside of the liver microsomal fraction 
used in this study. Furthermore, other toxic endpoints may 
be evaluated using these models to determine if AFB2a-
Arg has other non-genotoxic effects.
Another important aspect of treatment methods is 
their effect on the nutritional value of the foods to which 
they are applied. Oftentimes, these methods can vary the 
quantity of macronutrients or limit their absorption into the 
body [40–42]. Because AFB1 contamination commonly 
occurs in regions with high rates of malnutrition, it is 
important to maintain the integrity of the nutritional 
value of the detoxified food. Although this aspect of the 
treatment method was not evaluated in this study, organic 
acids have been extensively used on foods, usually as 
preservatives, nutritional supplements, or as naturally 
occurring constituents and have not been associated 
with reducing nutritional quality [43–51]. Regardless, 
a complete evaluation of this treatment process on the 
integrity of various foods commodities will be important 
towards establishing its practical use worldwide.
METHODS
Materials
Standards of aflatoxins, propranolol HCl, atenolol, 
LCMS grade solvents, L-arginine, citric acid, phosphoric 
acid, calf thymus DNA, pooled human plasma, and 
buffer reagents were purchased from Sigma Aldrich 
(St. Louis, MO). HepG2 cell line was purchased from 
ATCC (Manassas, VA). HepaRG cell line was purchased 
from Biopredic International (Saint Grégoire, France). 
HepaRG additives (ADD711) were purchased from 
Lonza (Walkersville, MD). Plates containing 21-day 
Caco-2 monolayers as well as Caco-2 assay buffers 
were purchased from MB Biosciences (Chestnut Hill, 
MA). Cells were all authenticated by manufacturers and 
were passaged for less than 6 months before collecting 
data for all experiments. All other cell culture materials, 
cell sorting set-up beads (for blue lasers), and rapid 
equilibrium dialysis plates (8K molecular weight cutoff) 
were purchased from Thermo Fisher Scientific (Waltham, 
MA). Ames’ test kits (Muta-chromoplate™) and rat liver 
microsomes were purchased from ebpi (Ontario, Canada). 
Figure 6: Summary of AFB1 detoxification through arginine adduction. By using acidic solutions containing arginine, AFB1 
can be converted prior to ingestion to AFB2a-Arg which had no measurable genotoxic effects and had favorable changes in toxicokinetic 
properties which would reduce liver tissue concentrations. This conversion prevents AFB1 from progressing down its natural genotoxic 
pathway of bioactivation to AFBO and subsequent binding to DNA at guanine residues.
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MicroFlow® In Vitro micronucleus kits were purchased 
from Litron Laboratories (Rochester, NY). AFB2a-
Arg was synthesized and purified according to previous 
methods published by our lab [29].
Cell culture conditions
HepG2 cells were cultured in Dulbecco’s Modified 
Eagle Medium (DMEM) high glucose media with 10% 
fetal bovine serum (FBS) and 1% penicillin-streptomycin. 
HepaRG cells were cultured using GlutaMAX 
supplemented Williams’ E Medium with 1% penicillin and 
a proprietary mixture of supplements provided by Lonza 
specifically made for HepaRG culturing. To differentiate 
HepaRG cells, cells were allowed to grow for 2 weeks and 
then the media was supplemented with 1.7% DMSO. Cells 
were then cultured in this DMSO-containing media for an 
additional 2 weeks to complete differentiation.
High performance liquid chromatography-mass 
spectrometry (HPLC-MS) conditions
Chemical analysis was performed using an Agilent 
1200 series high performance liquid chromatograph 
(HPLC) with an on-line Agilent 1200 series diode array 
detector connected to an Agilent 6220 time-of-flight mass 
spectrometer. The HPLC was equipped with an Agilent 
Zorbax Eclipse Plus C18 column (3.5 μm, 2.1 × 150 mm) 
held at 35° C. Mobile phases of water (solvent A) and 
50:50 methanol:acetonitrile (solvent B), each containing 
1% formic acid, were used at a flow rate of 0.25 mL/min. 
Gradient programming was as follows: 20% B at 0 min, 
ramp to 75% B at 4 min, and ramp to 100% B at 9 min. 
The diode array collected absorbance between 220 and 900 
nm throughout each run. Injection volume for all samples 
was 3 µL unless otherwise stated. Mass spectrometry data 
was collected in positive ionization mode with a nebulizer 
pressure of 35 psi and a capillary voltage of 3300 V. Data 
collection and analysis was performed using Agilent 
MassHunter software. 
AFB1 transformation using organic acids and 
arginine
Mixtures of AFB1 and aflatoxin M1 (AFM1) 
were prepared in acetonitrile (300 and 250 ng/mL 
respectively). Additionally, four stock solutions of 10 mg/
mL L-arginine were prepared in deionized water. Three 
of these aqueous solutions also contained citric acid 
(1 M), phosphoric acid (1 M), or a combination of citric 
and phosphoric acid (1 M each). Each of the four stocks 
were then divided into four containers and then adjusted 
to a pH of 2, 3, 4, or 5 using HCl and NaOH. Aliquots 
of 100 µL of the aflatoxin mixture were dried using a 
nitrogen evaporator and then reconstituted in 100 µL of 
each of the sixteen stock solutions. After dissolution in the 
aqueous solutions, each sample was boiled for 20 minutes 
and then injected into the HPLC-MS and analyzed for 
loss of AFB1 and formation of AFB2a-Arg using AFM1 
as an internal standard. All samples were repeated in 
triplicates. Statistical analysis was performed using two-
way ANOVAs, one-way ANOVAs, and Students’ t-tests.
Detoxification of spiked corn samples
Dry corn kernels were divided into three groups 
containing 2-3 grams of material. Corn was submerged 
in an acetonitrile solution containing AFB1. The amount 
of AFB1 solution was adjusted for each group to give 
100 ng of AFB1 per gram of corn. The acetonitrile was 
evaporated under nitrogen gas to give AFB1-spiked corn 
samples. After spiking, the first group was submerged in 
the treatment solution (1 M citric acid, 1 M phosphoric 
acid, 10 mg/mL arginine, pH 3), the second group was 
submerged in deionized water, and the third group did 
not receive any solution. The group that received the 
treatment solution was boiled for 20 minutes to mimic the 
transformation procedure provided earlier. The supernatant 
was collected for groups containing treatment solution 
or deionized water, spiked with 100 ng of aflatoxin B2 
(AFB2) as an internal standard, and extracted using 
Resprep C18 solid phase extraction (SPE) cartridges. 
SPE cartridges were conditioned with 3 mL methanol 
and equilibrated with 3 mL deionized water. Samples 
were loaded onto cartridges at a rate of 1–2 drops/sec. 
After drying under vacuum for 10 min, cartridges were 
eluted with 1 mL methanol and then analyzed by HPLC-
MS to determine the aflatoxin profile in the supernatants. 
Solid corn kernels from all three groups were extracted by 
adding 1 mL methanol containing 100 ng AFB2 and were 
vortexed for 10 sec. Methanol extracts were analyzed by 
HPLC-MS to determine aflatoxin species that remained on 
the corn kernels. A recovery factor was determined based 
on the untreated spiked samples and was used to correct 
for sample loss. Blank corn samples were also included 
for each group to subtract any background signal. All 
samples were repeated in triplicates. Statistical analysis 
was performed using one-way ANOVAs, and Students’ 
t-tests.
Stability of AFB1 and AFB2a-Arg in biological 
fluids
Simulated gastric and intestinal fluids were prepared 
according to U.S. Pharmacopeia formulations and pooled 
human plasma was purchased from Sigma Aldrich. AFB1 
and AFB2a-Arg was spiked into all three fluids to give a 
final concentration of 10 µM. Samples were analyzed by 
HPLC-MS at time zero (t0) and again at a final timepoint 
(tf) for each fluid (gastric tf = 1.5 hours, intestinal tf = 6 
hours, plasma tf = 18 hours). Because of high protein 
content in plasma samples, 25 µL of plasma was mixed 
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with 25 µL of cold acetonitrile containing 5 µg/mL AFB2 
and then centrifuged at 4° C at 13,000 g for 5 min to obtain 
a cleaner supernatant to inject into the HPLC-MS for both 
t0 and tf samples. Percent loss of AFB1 or AFB2a-Arg 
was calculated for each biological fluid. All samples were 
performed in triplicates. Statistical analysis was performed 
using one-way ANOVAs, and Students’ t-tests.
Microsomal stability
Rat-liver extracts and S9 activation reagents 
were purchased from ebpi and an S9 activation mixture 
containing MgCl2, KCl, glucose-6-phosphate, NADP, 
phosphate buffer, sterile distilled water, and rat-liver 
extract was prepared according to the manufacturer’s 
protocol. AFB1 or AFB2a-Arg were dissolved in the 
S9 mixture or PBS to give a final concentration of 40 
nM. Samples were incubated for 4 hours (tf) at 37° C. 
Samples were analyzed by HPLC-MS at t0 and tf to 
determine percent loss of each parent compound. 
Metabolite formation was identified by UV signals at each 
compound’s respective maximum absorption wavelengths 
(AFB1: 365 nm, AFB2a-Arg: 347 nm) and confirmed by 
accurate mass data by mass spectrometry. All samples 
were performed in triplicates. Statistical analysis was 
performed using one-way ANOVAs, and Students’ t-tests.
Determination of plasma protein binding by 
rapid equilibrium dialysis (RED) 
AFB1, AFB2a-Arg, propranolol (high binding 
control), and atenolol (low binding control) were each 
spiked into pooled human plasma to give individual 
solutions with a final concentration of 10 mM (<1% 
DMSO). Spiked plasma samples (200 µL) were dispensed 
into the sample chamber and PBS (350 µL) was dispensed 
into the buffer chamber of pre-conditioned, single-use 
RED plates. Plates were covered with sealing tape and 
placed on an orbital shaker set to 37° C and shaken at 
300 rpm for 4 hours. Seals were removed and 50 µL of 
each compartment for each compound was removed 
and placed into centrifuge tubes. To each tube, 50 µL of 
cold acetonitrile containing AFB2 (5 µg/mL) was added 
to precipitate proteins and release analytes. Samples 
were then centrifuged at 13,000 g for 5 min at 4° C. 
Supernatants were then injected into the HPLC-MS with 
injection volumes of 2 µL. All samples were performed in 
triplicates. Statistical analysis was performed using one-
way ANOVAs, and Students’ t-tests.
Octanol-water partition coefficient measurement
Individual standards of AFB1, AFB2a, and AFB2a-
Arg were prepared in deionized water (pH 7) at a 
concentration of 300 ng/mL each. Aliquots of 300 µL 
of each aqueous standard were added to 300 µL of 
1-octanol. Solutions were shaken at 1800 rpm for 5 min 
and then allowed to equilibrate for an additional 30 
minutes. Aqueous and organic layers for each sample were 
separated and analyzed by HPLC-MS. Octanol-water 
partition coefficients (P) were calculated as follows:
All samples were performed in triplicates. Statistical 
analysis was performed using one-way ANOVAs, and 
Students’ t-tests.
Caco-2 permeability assay
Assay plates containing 12 wells of 21-day Caco-2 
monolayers were provided by MB Biosciences. Monolayer 
integrity was verified using transepithelial electrical 
resistance measurements (TEER) prior to assay. Treatment 
solutions of AFB1, AFB2a, and AFB2a-Arg were prepared 
in the provided Hank’s buffered salt solution (HBSS) with 
a pH of 7.4 and a final DMSO concentration of 0.2%. 
Caco-2 monolayers were first rinsed with HBSS and then 
the apical chamber was filled with 500 µL of test 
compound solution while the basal chamber was filled 
with 1500 µL of blank HBSS (both chambers were kept at 
pH 7.4). Plates were incubated at 37°C for 2 hours to 
allow compound equilibration. Compound concentration 
was measured at t = 0 hrs and t = 2 hours by HPLC-MS. 
Permeability (Papp) was calculated as follows:
Where dQ/dt is the amount of translocated material 
over incubation time (nmol/s), A is the area of the insert 
(cm2), and C0 is the initial concentration of the test 
compound applied. Integrity of the monolayers was further 
verified with an atenolol control group which gave an 
acceptable Papp of < 0.5 × 10
6 cm/s. The test was also 
repeated in the reverse direction (basal chamber to apical 
chamber) to determine the efflux ratio (ER). ER was 
calculated as follows:
All samples were performed in triplicates. Statistical 
analysis was performed using Students’ t-tests.
Ames’ test for mutagenicity
A lyophilized mutant strain of Salmonella 
typhimurium (TA100) was purchased from ebpi along 
with all Ames’ test reagents. Bacteria were rehydrated in 
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nutrient broth the evening before the assay and allowed 
to incubate in an incubator held at 37° C for 16–18 hours. 
Individual solutions of AFB1 and AFB2a-Arg were 
prepared in sterile water with a DMSO concentration of 
0.1%. A reaction mixture containing Davis-Mingoli salts, 
D-glucose, bromocresol purple, D-biotin, and L-histidine 
was prepared according to kit protocol and mixed with the 
test compounds. Additionally, an S9 mixture containing 
MgCl2, KCl, glucose-6-phosphate, NADP, phosphate 
buffer, sterile distilled water, and rat-liver extract was 
also prepared according to kit protocol and added to each 
reaction tube. Lastly, each test solution received 5 µL of 
bacteria broth culture and was mixed thoroughly. The 
reaction mixtures containing test compounds and bacteria 
were dispensed into 96-well plates, sealed, and allowed 
to incubate at 37° C for 5 days. Both AFB1 and AFB2a-
Arg were each evaluated at 10, 30, and 50 ng/well along 
with a vehicle control. A blank group containing only kit 
reagents without treatment compounds or bacteria was 
added to ensure no contamination had occurred at any 
point throughout the assay. Each treatment group was 
dispensed into 48 wells. The number of positive wells 
(either yellow or turbid) was counted for each treatment 
group as a measure of mutagenicity. All treatments were 
performed in triplicates. Statistical analysis was performed 
using a chi-squared test according to previous methods 
[30] as per manufacturer’s recommendation.
DNA adduct identification
Aliquots of individual solutions of AFB1 and 
AFB2a-Arg (100 µL, 40 nM each) were dried under 
nitrogen and reconstituted in 100 µL of a 2.0 mg/mL 
solution of calf thymus DNA. Either the S9 mixture 
described earlier (100 µL) or PBS (100 µL) was added 
to each test compound and all samples were incubated at 
37° C for one hour. Afterwards, 600 µL of cold ethanol 
was added to all tubes to precipitate DNA. The supernatant 
was discarded and 120 µL of 0.15 M HCl was added to all 
tubes and then samples were incubated for 37° C for 5 
min. All samples were then injected into the HPLC-MS 
with an injection volume of 12 µL. Aflatoxin-adducts 
were qualitatively identified by monitoring each treatment 
compound at their respective maximum UV absorption 
wavelengths (AFB1: 365 nm, AFB2a-Arg: 347 nm) and 
confirmed by accurate mass data by mass spectrometry.
Analysis of micronuclei formation and 
cytotoxicity by flow cytometry
HepG2 and differentiated HepaRG cells were 
seeded in 96-well plates at a density of 3.0 × 104 cells/cm2, 
allowed to reattach for 24 hours, and then treated with 
either AFB1 or AFB2a-Arg for 24 hours in serum free 
media. Concentrations of test compounds began at 60 µM 
and were diluted 1:2 with serum free media to 0.9375 µM 
(DMSO concentration was 0.2%) along with a vehicle 
treated group for each cell type. Treatment solutions were 
aspirated and cells were allowed to recover in serum-
containing media for 72 hours which is equal to 1.5–2.0 
doubling times for both cell lines. The procedure for 
staining cells was provided in the kit provided by Litron 
Laboratories which was based off of previous methods 
[31, 32]. Briefly, plates were placed on ice and media 
was aspirated. Cells were then stained with Ethidium 
monoazide (EMA) and placed near a light source for 30 
min. Cells were protected from light and then lysed and 
stained with SYTOX Green. Cell sorting beads were also 
added to each well in equal amounts. Cells were analyzed 
using a Becton Dickinson (BD) LSR II analytical flow 
cytometer equipped with a BD high throughput sampler 
for 96 well plates. Data was collected using FACSDiva 
software version 8.0.1. Instrument settings and gating 
were performed according to kit protocol. Relative 
cell viability was determined by comparing the ratio of 
nuclei to beads of treated groups to the vehicle control. 
Percent micronuclei were measured for cells positive for 
SYTOX Green and negative for EMA. Micronuclei were 
only measured in treatment groups with a viability >25%. 
All treatments were performed in triplicates. Statistical 
analysis was performed using two-way ANOVAs, one-
way ANOVAs, and Students’ t-tests.
Abbreviations
AFB1: aflatoxin B1; AFB2a: aflatoxin B2a; 
AFB2a-Arg: aflatoxin B2a-arginine; AFBO: aflatoxin-
exo-8,9-epoxide; AFM1: aflatoxin M1; HCC: 
hepatocellular carcinoma; HPLC-MS: high performance 
liquid chromatography-mass spectrometry; RED: rapid 
equilibrium dialysis.
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